Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Lucid Diagnostics's Average Total Inventories for the quarter that ended in Mar. 2024 was $0.34 Mil. Lucid Diagnostics's Revenue for the
three
months ended in Mar. 2024 was $1.00 Mil.
Lucid Diagnostics's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.34.
Lucid Diagnostics's Inventory-to-Revenue for the quarter that ended in Mar. 2024
increased
from Dec. 2023 (0.23) to Dec. 2023 (0.34)
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Lucid Diagnostics's Days Inventory for the
three
months ended in Mar. 2024 was 18.96.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Lucid Diagnostics's Inventory Turnover for the quarter that ended in Mar. 2024 was 4.81.
Lucid Diagnostics Inventory-to-Revenue Historical Data
The historical data trend for Lucid Diagnostics's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Lucid Diagnostics's Inventory-to-Revenue
For the Medical Devices subindustry, Lucid Diagnostics's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lucid Diagnostics's Inventory-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lucid Diagnostics's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Lucid Diagnostics's Inventory-to-Revenue falls into.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Lucid Diagnostics's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Lucid Diagnostics's Days Inventory for the
three
months ended in Mar. 2024 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lucid Diagnostics Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Lucid Diagnostics's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Lucid Diagnostics (Lucid Diagnostics) Business Description
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LUCD has been successfully added to your 